Bioshield plan comes under questioning in Congress
Emergency Management Alert, April 10, 2003
Two weeks after approval from a Senate committee, President Bush's "Bioshield" proposal for encouraging commercial research and production of bioterror vaccine faced bipartisan questions on April 4 from the House Government Reform Committee, according to CongressDaily.
Lawmakers questioned aspects of the program, such as the loosening of government procurement rules and the waiver of Food and Drug Administration (FDA) approval for certain drugs in an emergency. Committee member Henry Waxman, D-CA, also noted that the plan limited the government's ability to sue companies that abuse contracts, adding that the FDA waiver could lead to the widespread distribution of unapproved drugs.
Officials from the Health and Human Services Department agreed to work with the committee to address any concerns. On the Senate side, the Bioshield proposal could reach the Senate floor the week of April 7.
Related Products
Most Popular
- Articles
-
- Featured blog post: Nurses face felony charges after reporting physician to the Texas Medical Board
- Topic: CMS, OESS post new security compliance review information, checklist
- HIPAA Q&A: Answering service messages
- Q/A: Volume requirement for reporting hydration services
- News and briefs: Oklahoma Osteopathic Association against residency bill change
- What does case-mix index mean to you?
- QA:Coding multiple initial infusions
- Are your workforce members texting PHI?
- OB services: Coding inside and outside of the package
- CMS issues IPPS proposed rule for FY 2013
- E-mailed
-
- Featured blog post: Nurses face felony charges after reporting physician to the Texas Medical Board
- Are your workforce members texting PHI?
- Don't let these sentinel events trigger falsely
- Arkansas woman convicted for HIPAA violation
- Reasons for inadequate fluid intake in the elderly
- Q&A tackles coding questions about injections and infusions
- Joint Commission Center announces handoff communication solutions
- Inside best practice: Reduce patient falls with a stoplight
- Identify modifiable risk factors to prevent patient falls
- Hospitalist-surgeon comanagement has no effect on outcomes
- Searched
